Adamu, S.M., Oyewole, O.S. and Kabir, U.F. 2024. Efficacy and safety of combination of poly-ADP-ribose polymerase inhibitor (PARPi) and chemotherapy compared with chemotherapy alone in treatment of recurrent ovarian carcinoma: a systematic review. Nigerian Medical Journal. 65, 1 (Apr. 2024), 1–15. DOI:https://doi.org/10.60787/nmj.v65i1.447.